All Stories

  1. What Can We Learn about the Bias of Microbiome Studies from Analyzing Data from Mock Communities?
  2. Testing microbiome associations with survival times at both the community and individual taxon levels
  3. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  4. Associations between microbial communities and key chemical constituents in U.S. domestic moist snuff
  5. Efficient estimation of indirect effects in case‐control studies using a unified likelihood framework
  6. LOCOM: A logistic regression model for testing differential abundance in compositional microbiome data with false discovery rate control
  7. A rarefaction-based extension of the LDM for testing presence–absence associations in the microbiome
  8. Multisample adjusted U-statistics that account for confounding covariates
  9. PhredEM: a phred-score-informed genotype-calling approach for next-generation sequencing studies
  10. Restoring the Duality between Principal Components of a Distance Matrix and Linear Combinations of Predictors, with Application to Studies of the Microbiome
  11. Testing Rare-Variant Association without Calling Genotypes Allows for Systematic Differences in Sequencing between Cases and Controls
  12. PhredEM: A Phred-Score-Informed Genotype-Calling Approach for Next-Generation Sequencing Studies
  13. Utilizing Population Controls in Rare-Variant Case-Parent Association Tests
  14. Robust Regression Analysis of Copy Number Variation Data based on a Univariate Score
  15. Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case–control study
  16. Risk Assessment and Evaluation of Predictions
  17. A Permutation Procedure to Correct for Confounders in Case-Control Studies, Including Tests of Rare Variation
  18. Stratification-Score Matching Improves Correction for Confounding by Population Stratification in Case-Control Association Studies
  19. Age-associated DNA methylation in pediatric populations
  20. California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case-control study
  21. Maternal smokeless tobacco use in Alaska Native women and singleton infant birth size
  22. Control for Confounding in Case-Control Studies Using the Stratification Score, a Retrospective Balancing Score
  23. A weighted accumulation test for associating rare genetic variation with quantitative phenotypes
  24. Inverse Probability of Censoring Weighted U-statistics for Right-Censored Data with an Application to Testing Hypotheses
  25. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  26. Microdeletions of 3q29 Confer High Risk for Schizophrenia
  27. Late Preterm Birth and Risk of Developing Asthma
  28. Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity
  29. Score-based adjustment for confounding by population stratification in genetic association studies
  30. Fast and Robust Association Tests for Untyped SNPs in Case-Control Studies
  31. SNPs in CAST are associated with Parkinson disease: A confirmation study
  32. A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease
  33. A Regression-based Association Test for Case-control Studies that Uses Inferred Ancestral Haplotype Similarity
  34. Effect of population stratification on the identification of significant single-nucleotide polymorphisms in genome-wide association studies
  35. Genome-wide association analysis of rheumatoid arthritis data via haplotype sharing
  36. MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasiveStreptococcus pyogenesisolates
  37. A Signed-Rank Test for Clustered Data
  38. Response to Lee et al.
  39. Robust estimation and testing of haplotype effects in case-control studies
  40. A Simple and Improved Correction for Population Stratification in Case-Control Studies
  41. Statistical Models for Haplotype Sharing in Case-Parent Trio Data
  42. Inference on haplotype/disease association using parent-affected-child data: the projection conditional on parental haplotypes method
  43. Association mapping via a class of haplotype-sharing statistics
  44. Simple methods for assessing haplotype-environment interactions in case-only and case-control studies
  45. Genetic Studies of a Cluster of Acute Lymphoblastic Leukemia Cases in Churchill County, Nevada
  46. Investigating Childhood Leukemia in Churchill County, Nevada
  47. Comment
  48. Improved association analyses of disease subtypes in case-parent triads
  49. Rank-Sum Tests for Clustered Data
  50. Cross-Sectional Study
  51. Genetic Association Analysis Using Data from Triads and Unrelated Subjects
  52. Genetic Analysis Workshop 14: microsatellite and single-nucleotide polymorphism marker loci for genome-wide scans
  53. Robust testing of haplotype/disease association
  54. Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens
  55. An empirical bayes adjustment to increase the sensitivity of detecting differentially expressed genes in microarray experiments
  56. Comparison of prospective and retrospective methods for haplotype inference in case-control studies
  57. How special is a 'special' interval: modeling departure from length-biased sampling in renewal processes
  58. Inference on Haplotype Effects in Case-Control Studies Using Unphased Genotype Data
  59. Random error and undercounting in birth defects surveillance data: Implications for inference
  60. Performance Characteristics of a New Less Sensitive HIV-1 Enzyme Immunoassay for Use in Estimating HIV Seroincidence
  61. HFE genotype and transferrin saturation in the United States
  62. Estimation of Stage Occupation Probabilities in Multistage Models
  63. Marginal Analyses of Clustered Data When Cluster Size Is Informative
  64. Informative Missingness in Genetic Association Studies: Case-Parent Designs
  65. Bootstrap calibration of TRANSMIT for informative missingness of parental genotype data
  66. Marginal Analyses of Multistage Data
  67. Estimation of Integrated Transition Hazards and Stage Occupation Probabilities for Non-Markov Systems Under Dependent Censoring
  68. HIV Seroincidence Among Patients at Clinics for Sexually Transmitted Diseases in Nine Cities in the United States
  69. HIV seroconverting donors delay their return: screening test implications
  70. Subtype-specific Transmission Probabilities for Human Immunodeficiency Virus Type 1 among Injecting Drug Users in Bangkok, Thailand
  71. Midrank unification of rank tests for exact, tied, and censored data
  72. Analysis of Dynamic Cohort Data
  73. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers
  74. Evaluation of a Sensitive/Less-Sensitive Testing Algorithm Using the 3A11-LS Assay for Detecting Recent HIV Seroconversion among Individuals with HIV-1 Subtype B or E Infection in Thailand
  75. Nonparametric Maximum Likelihood Estimation for Competing Risks Survival Data Subject to Interval Censoring and Truncation
  76. Accounting for Unmeasured Population Substructure in Case-Control Studies of Genetic Association Using a Novel Latent-Class Model
  77. Marginal estimation for multi-stage models: waiting time distributions and competing risks analyses
  78. Nonparametric Estimation for the Three-Stage Irreversible Illness-Death Model
  79. The S-U algorithm for missing data problems
  80. Conditional and Unconditional Categorical Regression Models with Missing Covariates
  81. Repeat Screening for HIV: When to Test and Why
  82. Estimating the Extent of Tracking in Interval-Censored Chain-Of-Events Data
  83. Validating Marker-Based Incidence Estimates in Repeatedly Screened Populations
  84. Detection of Early HIV Infection and Estimation of Incidence Using a Sensitive/Less-Sensitive Enzyme Immunoassay Testing Strategy at Anonymous Counseling and Testing Sites in San Francisco
  85. Hold everything! Holding policies for protecting plasma supplies
  86. Fitting Semi-Markov Models to Interval-Censored Data with Unknown Initiation Times
  87. Discrete-Time Nonparametric Estimation for Semi-Markov Models of Chain-of-Events Data Subject to Interval Censoring and Truncation
  88. Kaplan–Meier representation of competing risk estimates
  89. HIV Seroincidence and Risk Factors Among Patients Repeatedly Tested for HIV Attending Sexually Transmitted Disease Clinics in the United States, 1991 to 1996
  90. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis
  91. New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes
  92. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  93. Inference Based on Imputed Failure Times for the Proportional Hazards Model with Interval-Censored Data
  94. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
  95. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire
  96. Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors
  97. Markov Chains With Measurement Error: Estimating the `True' Course of a Marker of the Progression of Human Immunodeficiency Virus Disease
  98. Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States
  99. Upper and Lower Bound Distributions that Give Simultaneous Confidence Intervals for Quantiles
  100. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors
  101. Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia
  102. Estimation of Incidence of HIV Infection Using Cross-Sectional Marker Surveys
  103. Direct oral questions to blood donors: the impact on screening for human immunodeficiency virus
  104. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group
  105. Probability of female-to-male transmission of HIV-1 in Thailand
  106. Conditional Regression Analysis of the Exposure-Disease Odds Ratio Using Known Probability-of-Exposure Values
  107. [Backcalculation of HIV Infection Rates]: Comment
  108. Inferences About Exposure-Disease Associations Using Probability-of-Exposure Information
  109. Inferences About Exposure-Disease Associations Using Probability-of- Exposure Information
  110. HIV Infection among Patients in U.S. Acute Care Hospitals
  111. Continued Fraction Representation for Expected Cell Counts of a 2 x 2 Table: A Rapid and Exact Method for Conditional Maximum Likelihood Estimation
  112. Sample size determination for pair-matched case-control studies where the goal is interval estimation of the odds ratio
  113. Critical phenomena in randomly stirred fluids: Correlation functions, equation of motion, and crossover behavior
  114. Critical phenomena in randomly stirred fluids
  115. Modification of nonequilibrium fluctuations by interaction with surfaces